Joint Venture Contract Services – A CDMO’S Approach To Being A True Partner […]
Category: News
What makes BIOVECTRA a “Leader in today’s competitive CDMO market.”
What makes BioVectra a “Leader in today’s competitive CDMO market.” […]
Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies
Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies […]
BIOVECTRA – Hiring Practices – The Employment Journey on PEI
BioVectra is a custom manufacturer of pharmaceutical ingredients for pharma companies. […]
BIOVECTRA Announces Acquisition of Former Sunovion (Sepracor) Facility
June 23, 2014 BIOVECTRA Announces Acquisition of Former Sunovion (Sepracor) Facility BIOVECTRA, a specialized cGMP manufacturer, and developer of pharmaceutical ingredients has announced today that it has agreed to purchase the previous Sepracor Canada Limited facility at Windsor, Nova Scotia, for an undisclosed sum. View Article […]
BIOVECTRA Spending $3.8 Million on Expansion
June 14, 2014 BIOVECTRA Spending $3.8 Million on Expansion An Island company that has been in business for more than 40 years is growing as BIOVECTRA invests $3.8 million to expand one of its facilities in Charlottetown. View Article […]
BIOVECTRA Starts Construction to Expand Charlottetown Facility
June 11, 2014 BIOVECTRA Starts Construction to Expand Charlottetown Facility BIOVECTRA, a specialized manufacturer and developer of pharmaceutical ingredients for the global marketplace, has commenced the expansion of one of its Prince Edward Island facilities, located at 11 Aviation Avenue, adjacent to the Charlottetown airport. View Article […]
Risk Management in Financing of Capital Expansions
BioVectra Inc. is an eastern Canadian contract manufacturing organization (CMO) with expertise in both synthetic chemistry and biomanufacturing techniques. […]
BIOVECTRA Named Agent of Reagent Proteins’ Products
June 25, 2013 BIOVECTRA Named Agent of Reagent Proteins’ Products BIOVECTRA announced today a new agreement naming BIOVECTRA as a non-exclusive agent of Reagent Proteins in North America and Europe. BIOVECTRA will provide its customers access to Reagent Proteins’ unique range of over 5,000 catalog protein products; as well as actively promoting Reagent Proteins’ capabilities […]